1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. PROPHASE LABS INC
ProPhase Labs Inc XNAS: PRPH
1.00 0.91 (1011.11%)
3.0M

XNAS 22 Dec, 2025 10:58 AM (EST)

Watchlist

Portfolio

Alert

Split
ProPhase Labs Inc had split the face value of its shares from $1 to $10 on 22 Dec 2025. See details

ProPhase Labs Inc - PRPH - stock price prediction, stock price target, analyst ratings

ProPhase Labs Inc has a share price target of US$ 14, revenue growth forecast of 214.1%, and profit growth estimate of 78.7% for FY25